ALVO Valuation

Alvotech SA

Add to Watchlist

Advanced Chart

8.070

+0.02(0.248%)1D

Overview
Forecast
Valuation
Earnings

ALVO Relative Valuation

ALVO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALVO is overvalued; if below, it's undervalued.

Historical Valuation

Alvotech SA (ALVO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.26 is considered Undervalued compared with the five-year average of -21.73. The fair price of Alvotech SA (ALVO) is between 14.68 to 37.41 according to relative valuation methord. Compared to the current price of 8.07 USD , Alvotech SA is Undervalued By 45.04%.

Relative Value

Fair Zone

14.68-37.41

Current Price：8.07

45.04%

Undervalued

18.17

Trailing

Forward

11.43

EV/EBITDA

Alvotech SA. (ALVO) has a current EV/EBITDA of 11.43. The 5-year average EV/EBITDA is -2.98. The thresholds are as follows: Strongly Undervalued below -58.99, Undervalued between -58.99 and -30.99, Fairly Valued between 25.02 and -30.99, Overvalued between 25.02 and 53.02, and Strongly Overvalued above 53.02. The current Forward EV/EBITDA of 11.43 falls within the Historic Trend Line -Fairly Valued range.

10.95

EV/EBIT

Alvotech SA. (ALVO) has a current EV/EBIT of 10.95. The 5-year average EV/EBIT is 4.54. The thresholds are as follows: Strongly Undervalued below -70.34, Undervalued between -70.34 and -32.90, Fairly Valued between 41.98 and -32.90, Overvalued between 41.98 and 79.43, and Strongly Overvalued above 79.43. The current Forward EV/EBIT of 10.95 falls within the Historic Trend Line -Fairly Valued range.

3.26

Alvotech SA. (ALVO) has a current PS of 3.26. The 5-year average PS is 6.35. The thresholds are as follows: Strongly Undervalued below -5.15, Undervalued between -5.15 and 0.60, Fairly Valued between 12.09 and 0.60, Overvalued between 12.09 and 17.84, and Strongly Overvalued above 17.84. The current Forward PS of 3.26 falls within the Historic Trend Line -Fairly Valued range.

12.76

P/OCF

Alvotech SA. (ALVO) has a current P/OCF of 12.76. The 5-year average P/OCF is -2.98. The thresholds are as follows: Strongly Undervalued below -52.24, Undervalued between -52.24 and -27.61, Fairly Valued between 21.65 and -27.61, Overvalued between 21.65 and 46.28, and Strongly Overvalued above 46.28. The current Forward P/OCF of 12.76 falls within the Historic Trend Line -Fairly Valued range.

12.35

P/FCF

Alvotech SA. (ALVO) has a current P/FCF of 12.35. The 5-year average P/FCF is 2.68. The thresholds are as follows: Strongly Undervalued below -29.72, Undervalued between -29.72 and -13.52, Fairly Valued between 18.87 and -13.52, Overvalued between 18.87 and 35.07, and Strongly Overvalued above 35.07. The current Forward P/FCF of 12.35 falls within the Historic Trend Line -Fairly Valued range.

Alvotech SA (ALVO) has a current Price-to-Book (P/B) ratio of -14.51. Compared to its 3-year average P/B ratio of -6.18 , the current P/B ratio is approximately 134.82% higher. Relative to its 5-year average P/B ratio of -4.20, the current P/B ratio is about 245.11% higher. Alvotech SA (ALVO) has a Forward Free Cash Flow (FCF) yield of approximately -4.86%. Compared to its 3-year average FCF yield of -11.53%, the current FCF yield is approximately -57.85% lower. Relative to its 5-year average FCF yield of -21.91% , the current FCF yield is about -77.83% lower.

-14.51

P/B

Median3y

-6.18

Median5y

-4.20

-4.86

FCF Yield

Median3y

-11.53

Median5y

-21.91

Competitors Valuation Multiple

The average P/S ratio for ALVO's competitors is 23.74, providing a benchmark for relative valuation. Alvotech SA Corp (ALVO) exhibits a P/S ratio of 3.26, which is -86.25% above the industry average. Given its robust revenue growth of -12.79%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Denali Therapeutics Inc

111.87

2.23B

APGE.O

Apogee Therapeutics Inc

Performance Decomposition

Market capitalization of ALVO decreased by 32.18% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 29.85 to 37.10.

The secondary factor is the Revenue Growth, contributed -12.79%to the performance.

Overall, the performance of ALVO in the past 1 year is driven by P/E Change. Which is more unsustainable.

-12.79%

198.75M → 173.34M

Revenue Growth

-43.69%

32.82 → 18.48

Margin Expansion

24.30%

29.85 → 37.10

P/E Change

-32.18%